This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 May;76(3):221-3.

doi: 10.1016/j.jbspin.2009.01.005. Epub 2009 Apr 11.

Thiazolidinediones: antidiabetic agents with effects on bone

Françoise Debiais

PMID: 19362505
DOI: 10.1016/j.jbspin.2009.01.005

Editorial

Thiazolidinediones: antidiabetic agents with effects on bone

Françoise Debiais. Joint Bone Spine. 2009 May.

. 2009 May;76(3):221-3.

doi: 10.1016/j.jbspin.2009.01.005. Epub 2009 Apr 11.

Author

Françoise Debiais

PMID: 19362505
DOI: 10.1016/j.jbspin.2009.01.005

No abstract available

PubMed Disclaimer

Similar articles

Effect of thiazolidinediones on skeletal health in women with Type 2 diabetes.
Schwartz AV, Sellmeyer DE. Schwartz AV, et al. Expert Opin Drug Saf. 2008 Jan;7(1):69-78. doi: 10.1517/14740338.7.1.69. Expert Opin Drug Saf. 2008. PMID: 18171315 Review.
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial.
Gruntmanis U, Fordan S, Ghayee HK, Abdullah SM, See R, Ayers CR, McGuire DK. Gruntmanis U, et al. Calcif Tissue Int. 2010 May;86(5):343-9. doi: 10.1007/s00223-010-9352-5. Epub 2010 Mar 31. Calcif Tissue Int. 2010. PMID: 20354684 Clinical Trial.
Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled study.
Bone HG, Lindsay R, McClung MR, Perez AT, Raanan MG, Spanheimer RG. Bone HG, et al. J Clin Endocrinol Metab. 2013 Dec;98(12):4691-701. doi: 10.1210/jc.2012-4096. Epub 2013 Sep 20. J Clin Endocrinol Metab. 2013. PMID: 24057294 Clinical Trial.
Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men.
Yaturu S, Bryant B, Jain SK. Yaturu S, et al. Diabetes Care. 2007 Jun;30(6):1574-6. doi: 10.2337/dc06-2606. Epub 2007 Mar 15. Diabetes Care. 2007. PMID: 17363747 No abstract available.
Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis.
Lecka-Czernik B. Lecka-Czernik B. Curr Osteoporos Rep. 2010 Dec;8(4):178-84. doi: 10.1007/s11914-010-0027-y. Curr Osteoporos Rep. 2010. PMID: 20809203 Free PMC article. Review.

See all similar articles

Cited by

Causes, consequences, and treatment of osteoporosis in men.
Banu J. Banu J. Drug Des Devel Ther. 2013 Aug 22;7:849-60. doi: 10.2147/DDDT.S46101. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24009413 Free PMC article. Review.
Synthesis and biological evaluation of the new 1,3-dimethylxanthine derivatives with thiazolidine-4-one scaffold.
Constantin S, Lupascu FG, Apotrosoaei M, Vasincu IM, Lupascu D, Buron F, Routier S, Profire L. Constantin S, et al. Chem Cent J. 2017 Feb 1;11:12. doi: 10.1186/s13065-017-0241-0. eCollection 2017. Chem Cent J. 2017. PMID: 28203273 Free PMC article.
Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms.
Wongdee K, Charoenphandhu N. Wongdee K, et al. World J Diabetes. 2011 Mar 15;2(3):41-8. doi: 10.4239/wjd.v2.i3.41. World J Diabetes. 2011. PMID: 21537459 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information